Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Gaber, A. O. et al. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Transplantation 86, 1187–1195 (2008).
2. Halloran, P. F. Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351, 2715–2729 (2004).
3. Mahoney, R. J., Norman, D. J., Colombe, B. W., Garovoy, M. R. & Leeber, D. A. Identification of high- and low-risk second kidney grafts. Transplantation 61, 1349–1355 (1996).
4. [No authors listed] USRDS 2008 Annual Data Report: Atlas of End-stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. http://www.usrds.org/adr.htm
5. Mange, K. C., Joffe, M. M. & Feldman, H. I. Effect of the use or nonuse of long-term dialysis on the subsequent survival of renal transplants from living donors. N. Engl. J. Med. 344, 726–731 (2001).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献